Volume | 4,417,775 |
|
|||||
News | - | ||||||
Day High | 11.87 | Low High |
|||||
Day Low | 11.40 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Organon and Co | OGN | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
11.42 | 11.40 | 11.87 | 11.83 | 11.50 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
34,170 | 4,417,775 | $ 11.68 | $ 51,588,152 | - | 10.905 - 32.43 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:35:03 | 3 | $ 11.81 | USD |
Organon (OGN) Options Flow Summary
Organon and Co Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.02B | 255.61M | - | 6.17B | 917M | 3.59 | 3.29 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Organon News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OGN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.33 | 11.87 | 11.17 | 11.39 | 4,169,865 | 0.50 | 4.41% |
1 Month | 13.23 | 13.23 | 10.905 | 11.55 | 4,267,034 | -1.40 | -10.58% |
3 Months | 19.35 | 19.96 | 10.905 | 15.08 | 4,997,454 | -7.52 | -38.86% |
6 Months | 19.89 | 24.08 | 10.905 | 17.04 | 3,438,345 | -8.06 | -40.52% |
1 Year | 26.55 | 32.43 | 10.905 | 20.11 | 2,779,293 | -14.72 | -55.44% |
3 Years | 34.20 | 39.475 | 10.905 | 26.49 | 2,460,937 | -22.37 | -65.41% |
5 Years | 34.20 | 39.475 | 10.905 | 26.49 | 2,460,937 | -22.37 | -65.41% |
Organon Description
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. |